DoubleChecks

What was claimed

To sell CHEMOTHERAPY as a 'therapy' is the biggest deceit in the history of medicine [...] A 2004 Clinical Oncology study found cytotoxic chemotherapy contributes to only ~2.3% of 5-year survival in adult cancers.

Our verdict

Inaccurate

Chemotherapy is an established, evidence-based treatment that significantly improves survival and cure rates in multiple cancers such as testicular cancer, many leukemias and lymphomas, and pediatric malignancies, where 5‑year survival often exceeds 80–90% with modern chemotherapy-based regimens. Calling it “the biggest deceit” is a value judgment that ignores extensive clinical trial data and long-term outcomes showing clear therapeutic benefit. The 2.3% was an aggregate across 22 specific malignancies for curative and adjuvant treatment only. Survival rates vary drastically by cancer type and stage. The study's authors noted their estimates were upper limits of effectiveness, and chemotherapy is typically combined with surgery and radiotherapy, making isolated attribution difficult.

0 of 3 AI systems agree15 sources citedChecked Aug 20, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

To sell CHEMOTHERAPY as a 'therapy' is the biggest deceit in the history of medicine.

Incorrect95%
1 of 3 AIs agree·Claude: Misleading, ChatGPT: Can’t verify

The 2.3% figure represents chemotherapy's overall contribution to cancer survival

Misleading85%
1 AI checked

A 2004 Clinical Oncology study found cytotoxic chemotherapy contributes to only ~2.3% of 5-year survival in adult cancers.

Verified95%
2 of 3 AIs agree·Perplexity: Misleading

Verified against 15 sources

pubmed.ncbi.nlm.nih.govsciencedirect.comkanker-actueel.nlscispace.comicnr.comscribd.commetododibella.orgsci-hub.sepdfs.semanticscholar.orghealingcancernaturally.comiangawler.compubmed.ncbi.nlm.nih.govarxiv.orgscienceinsights.orggreensmoothiegirl.com

Detailed Analysis

The numerical citation of the 2004 Clinical Oncology study is broadly accurate, but its use is highly misleading. The sweeping statement that chemotherapy is not a genuine therapy and that the study shows it is almost useless contradicts modern oncology evidence and misrepresents the study’s narrow scope.

Why this verdict

  • The numerical citation of the 2004 Clinical Oncology study is broadly accurate, but its use is highly misleading.
  • The sweeping statement that chemotherapy is not a genuine therapy and that the study shows it is almost useless contradicts modern oncology evidence and misrepresents the study’s narrow scope.

Claims checked

To sell CHEMOTHERAPY as a 'therapy' is the biggest deceit in the history of medicine.

Incorrect95%
Chemotherapy is an established, evidence-based treatment that significantly improves survival and cure rates in multiple cancers such as testicular cancer, many leukemias and lymphomas, and pediatric malignancies, where 5‑year survival often exceeds 80–90% with modern chemotherapy-based regimens.[1] [4] [9] [14] Calling it “the biggest deceit” is a value judgment that ignores extensive clinical trial data and long-term outcomes showing clear therapeutic benefit.

This claim may mislead readers without added context.

A 2004 Clinical Oncology study found cytotoxic chemotherapy contributes to only ~2.3% of 5-year survival in adult cancers.

Misleading95%
The 2004 Clinical Oncology paper by Morgan, Ward, and Barton did estimate the overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults as 2.3% in Australia and 2.1% in the USA across 22 malignancies diagnosed in 1998.[1] [2] [3] [6] [8] [9] However, this figure is an average across all adult cancers, including many where chemotherapy is not the primary treatment, and the authors themselves note that chemotherapy makes a much larger contribution in specific cancers and that their 2–3% estimate is an upper limit for that period; using it to claim chemotherapy generally “only” helps 2% of patients oversimplifies and misrepresents the study’s scope and context.[4] [5] [11] [14] [15]

This claim may mislead readers without added context.

What other AI think

The 2.3% figure is accurately cited from the 2004 Morgan study, but the statement's framing is misleading. The study measured only curative and adjuvant chemotherapy across 22 malignancies, not all chemotherapy uses. Survival rates vary dramatically by cancer type, and the authors noted their estimates were upper limits. The inflammatory characterization of chemotherapy as "the biggest deceit" is unsupported opinion, not fact.

Why this verdict

  • The 2.3% figure is accurately cited from the 2004 Morgan study, but the statement's framing is misleading.
  • The study measured only curative and adjuvant chemotherapy across 22 malignancies, not all chemotherapy uses.
  • Survival rates vary dramatically by cancer type, and the authors noted their estimates were upper limits.
  • The inflammatory characterization of chemotherapy as "the biggest deceit" is unsupported opinion, not fact.

Claims checked

The 2.3% figure represents chemotherapy's overall contribution to cancer survival

Misleading85%
The 2.3% was an aggregate across 22 specific malignancies for curative and adjuvant treatment only. Survival rates vary drastically by cancer type and stage. The study's authors noted their estimates were upper limits of effectiveness, and chemotherapy is typically combined with surgery and radiotherapy, making isolated attribution difficult.

This claim may mislead readers without added context.

Selling chemotherapy as a 'therapy' is the biggest deceit in the history of medicine

Misleading90%
This is inflammatory rhetoric unsupported by evidence. Chemotherapy effectiveness varies dramatically by cancer type (92% for early-stage breast cancer vs. 10% for adult T-cell leukemia). The 2004 study itself did not make this sweeping claim; it called for rigorous evaluation of cost-effectiveness and quality of life.

This claim may mislead readers without added context.

A 2004 Clinical Oncology study found cytotoxic chemotherapy contributes to only ~2.3% of 5-year survival in adult cancers

Verified95%
The Morgan et al. 2004 study in Clinical Oncology did report 2.3% contribution in Australia and 2.1% in the USA. However, this applied specifically to curative and adjuvant chemotherapy across 22 malignancies, not all cancer types or all chemotherapy uses.
The numerical statement about the 2004 paper is accurate. However the sweeping claim that selling chemotherapy as a 'therapy' is "the biggest deceit in the history of medicine" is an opinion and misleading when paired with that single statistic.

Why this verdict

  • The numerical statement about the 2004 paper is accurate.
  • However the sweeping claim that selling chemotherapy as a 'therapy' is "the biggest deceit in the history of medicine" is an opinion and misleading when paired with that single statistic.

Claims checked

To sell CHEMOTHERAPY as a 'therapy' is the biggest deceit in the history of medicine.

Can’t verify60%
This is a subjective value judgment, not an empirical claim that can be verified; pairing it with a single statistic is misleading because chemotherapy has proven survival benefits in many cancers and contexts not fully captured by the paper's narrow methodology.

A 2004 Clinical Oncology study found cytotoxic chemotherapy contributes to only ~2.3% of 5-year survival in adult cancers.

Verified95%
The 2004 Clinical Oncology paper by Morgan et al. estimated the contribution of curative/adjuvant cytotoxic chemotherapy to 5-year survival as about 2.3% for Australia (≈2.1% for the USA).

Share this result

Try DoubleChecks